NFKB1 and Lassa fever: Therefore, the anti-inflammatory effects of EA observed in these studies, specifically its downregulation of the HMGB1/NF-κB pathway, suggest its potential therapeutic value for conditions like LSS, where similar NF-κB-mediated inflammation is implicated in LF pathology.